These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 26803494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B, Golabek A, Kida E, Rabe A, Hwang YW, Adayev T, Wegiel J, Flory M, Kaczmarski W, Marchi E, Frackowiak J.
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
    Toiber D, Azkona G, Ben-Ari S, Torán N, Soreq H, Dierssen M.
    Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
    [Abstract] [Full Text] [Related]

  • 6. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X, Martín ED, Ortiz-Abalia J, Valderrama A, Lao-Peregrín C, Dierssen M, Fillat C.
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis.
    Kim Y, Park J, Song WJ, Chang S.
    Neurosignals; 2010 Apr; 18(3):164-72. PubMed ID: 21135538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
    Thomas JR, Sloan K, Cave K, Wallace JM, Roper RJ.
    Genes (Basel); 2021 Oct 28; 12(11):. PubMed ID: 34828335
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR, Cho HJ, Lee HW, Jeong HK, Radnaabazar C, Kim YS, Kim MJ, Son MY, Seo H, Chung SH, Song WJ.
    J Neurochem; 2008 Mar 28; 104(5):1333-44. PubMed ID: 18005339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
    Altafaj X, Dierssen M, Baamonde C, Martí E, Visa J, Guimerà J, Oset M, González JR, Flórez J, Fillat C, Estivill X.
    Hum Mol Genet; 2001 Sep 01; 10(18):1915-23. PubMed ID: 11555628
    [Abstract] [Full Text] [Related]

  • 16. Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model.
    Hawley LE, Stringer M, Deal AJ, Folz A, Goodlett CR, Roper RJ.
    Neurobiol Dis; 2024 Jan 01; 190():106359. PubMed ID: 37992782
    [Abstract] [Full Text] [Related]

  • 17. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I, Barrachina M, Puig B, Martínez de Lagrán M, Martí E, Avila J, Dierssen M.
    Neurobiol Dis; 2005 Nov 01; 20(2):392-400. PubMed ID: 16242644
    [Abstract] [Full Text] [Related]

  • 18. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons.
    Martinez de Lagran M, Benavides-Piccione R, Ballesteros-Yañez I, Calvo M, Morales M, Fillat C, Defelipe J, Ramakers GJ, Dierssen M.
    Cereb Cortex; 2012 Dec 01; 22(12):2867-77. PubMed ID: 22215728
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome).
    Cárdenas AM, Fernández-Olivares P, Díaz-Franulic I, González-Jamett AM, Shimahara T, Segura-Aguilar J, Caviedes R, Caviedes P.
    Neurotox Res; 2017 Nov 01; 32(4):614-623. PubMed ID: 28695546
    [Abstract] [Full Text] [Related]

  • 20. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
    Hämmerle B, Elizalde C, Tejedor FJ.
    Eur J Neurosci; 2008 Mar 01; 27(5):1061-74. PubMed ID: 18364031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.